Has Jesse Weinberger, MD received payments from drug or device companies?

Yes. Drug and device makers reported $143,947 in general payments to Jesse Weinberger, MD across 163 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jesse Weinberger, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jesse Weinberger, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jesse Weinberger, MD

Neurology · New York, NYNPI 1447221551

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $143,896 of the $143,947 with a category attached, or 100.0%. Abbott accounts for 97.5% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $33,382 and has fallen 93.3% since, to $2,250 in 2025. Among neurology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$143,947in general payments, 2019–2025

Across 163 payments — averaging $883.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$140K
Daiichi Sankyo Inc.$4K
AbbVie$51

What the payments were for

Consulting fees$143,896100%
Food & beverage$510%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	157	$140,396
Daiichi Sankyo Inc.	4	$3,500
AbbVie	2	$51

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

PORTICO$50,000
Mitra Clip system$23,000
Portico Transcatheter Aortic Heart Valve$20,500
Portico Transcatheter Aortic HV$19,500
Xience V coronary stent system$5,250
Tricuspid Valve Repair System$4,750
Savaysa$3,500
Absorb GT1$2,500
XIENCE SKYPOINT$2,250
Xience cornary stent systems$2,000
XIENCE V$2,000
MitraClip System$1,000
Gallant CRT-D$250

How this compares

$143,947 in reported general payments places this provider in the 95th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York →

Medicare billing

Part B allowed, 2024

$143,505

Medicare patients

814

Services billed

2,411

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	21	$19,582
Galantamine ErGalantamine Hbr	52	$2,532
Levetiracetam	105	$1,525
Carbidopa-LevodopaCarbidopa/Levodopa	60	$1,263
Donepezil Hcl	85	$1,151
Quetiapine Fumarate	33	$818
Gabapentin	84	$784
Pregabalin	21	$684
Rasagiline Mesylate	11	$640
Duloxetine Hcl	30	$601
Escitalopram Oxalate	17	$551
Atorvastatin Calcium	33	$510
ClopidogrelClopidogrel Bisulfate	43	$449
Ezetimibe	11	$415
Memantine Hcl	13	$334

Paid to pharmacies, not to this prescriber.

Other neurology in New York

Stephen KriegerNew York$1.1M
Sheng-Han KuoNew York$657K
Timothy VartanianNew York$468K
Steven WolfNew York$428K
David DodickNew York$426K
David SimpsonNew York$403K
Fred LublinNew York$383K
Alexander ShtilbansNew York$374K
Andrew LassmanNew York$359K
Brian ApatoffNew York$295K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →